Candel Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -149 | -163 | -195 | |
EBITDA | -37,010 | -7,148 | -27,917 | -10,913 |
EBIT | -37,330 | -7,297 | -28,080 | -11,108 |
Net Income | -38,905 | -8,861 | -29,496 | -11,269 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,251 | -18,712 | -10,977 | -10,380 |
Cash | 201,565 | 194,834 | 119,731 | 86,963 |
Basic Shares | 74,131 | 62,361 | 54,898 | 54,894 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $31 | $125 |
Gross Profit | -845 | -990 | -23,980 | 125 |
EBITDA | -35,218 | -52,097 | -34,384 | -16,308 |
EBIT | -36,063 | -53,087 | -35,344 | -17,086 |
Net Income | -38,182 | -55,177 | -37,939 | -18,794 |
Net Change In Cash | 0 | 0 | 31 | 125 |
Free Cash Flow | -38,898 | -27,039 | -34,701 | -32,716 |
Cash | 119,731 | 102,654 | 35,413 | 70,058 |
Basic Shares | 52,958 | 31,675 | 28,935 | 28,823 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.35 |
2026-03-31 | -$0.14 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.23 |